UniProtKB/SwissProt variant VAR

Variant information

Variant position:

459

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LB/B

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glutamate (E) to Aspartate (D) at position 459 (E459D, p.Glu459Asp).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and acidic.

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

2

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Other resources:

Links to websites of interest for the variant.

Variant rs500611 [ dbSNP | Ensembl ]

Sequence information

Variant position:

459

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

512

The length of the canonical sequence.

Location on the sequence:

TIKDHWLKHPGLAQLCVTIE E CWDHDAEARLSAGCVEERVS

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         TIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEERVS

Mouse                         TIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEERVS

Rat                           TIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEERVS

Pig                           AIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEERVS

Bovine                        AIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEERVS

Chicken                       VFKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEERIA

Xenopus laevis                VFKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEERIS

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	19 – 512	Activin receptor type-2B
Topological domain	159 – 512	Cytoplasmic
Domain	190 – 480	Protein kinase
Helix	448 – 460

Literature citations

Genomic organization and mapping of the human activin receptor type IIB (hActR-IIB) gene.
Ishikawa S.; Kai M.; Murata Y.; Tamari M.; Daigo Y.; Murano T.; Ogawa M.; Nakamura Y.;
J. Hum. Genet. 43:132-134(1998)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANT ASP-459;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q13705: Variant p.Glu459Asp